What are the responsibilities and job description for the Senior Medical Science Liaison, Field Medical position at Jobleads-US?
From research and discovery to post-market clinical development, our engine involves all bench and clinical research and the associated groups that support those endeavors.
Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with genetic diseases.
BioMarin's Research & Development group is responsible for everything from research and discovery to post-market clinical development.
The Skeletal Conditions (SC) Medical Science Liaison (MSL) / Senior MSL
This position supports the scientific and business interests of BioMarin by cultivating current and future thought leaders in academic and clinical medicine at the local, regional, and national level through in-depth, fair-balanced scientific exchange and strategic insight gathering.
MSLs are the primary communicators of BioMarin science within a specific geography with healthcare providers and other key stakeholders and are viewed as peer scientific experts in a designated therapeutic area.
Key Responsibilities:
- IDentify pre-clinical, clinical, and post-marketing study investigators in alignment with the SC Medical Affairs objectives.
- Provide actionable information and insights to internal stakeholders that may enhance the value and appropriate use of BioMarin products.
- Support the initiation and development of Investigator Research proposals (IRs).
The Senior MSL must possess in-depth knowledge of BioMarin's approved product, pipeline research, and all associated disease state areas.
The MSL / Senior MSL is a team player and possesses the capacity to coordinate and manage initiatives or partnerships with external partners independently or with a minimum amount of oversight.
This position will report into the Senior Director, SC Medical Unit within the Global Medical Affairs (GMAF) organization.
Execute SC medical MSL plan and tactics within assigned territory to meet scientific objectives and company-defined goals for products both marketed and in development.
Development and periodic refinement of an approved MSL Territory Plan designed to support and meet strategic medical objectives.
Provide education relative to disease state and BioMarin products across product lifecycle to health care providers among specialties including Genetics, Pediatric Endocrinology, Pediatric Orthopedics, and other relevant specialties.
Serve as a medical/scientific resource through answering unsolicited medical questions and addressing other related medical information queries.
Engage in scientific exchange and provide feedback on emerging clinical/competitive trends.
Identify, document, discuss and communicate insights to internal stakeholders.
Partner with medical and research groups and compliantly collaborate with the commercial team.
Support clinical operations in identifying and interacting with potential investigators for BioMarin products in development as per Medical Affairs therapeutic area plan.
Support the implementation and coordination of external investigator-initiated research.
Participate in local, regional, and national meetings/conferences in support of all scientific and medical objectives.
Review scientific journals, lead, and participate in internal journal clubs.
Serve as a scientific resource to commercial and marketing partners. Participate in sales team training, medical updates, scientific presentations, journal clubs, and other approved meetings as appropriate.
Have responsibility for assigned special projects and mentoring of other team members.
BA/BS in life or health sciences; Experience in rare genetic diseases, ACH and/or Skeletal Dysplasia therapy preferred.
Knowledge of regulations impacting Medical Affairs and field activities in the pharmaceutical industry.
Project management understanding and experience.
Ability to work in a virtual environment and knowledge of virtual and collaborative systems.
Position will require travel for field engagements and Specialty Congresses (50%-70%).